^
BIOMARKER:

MET amplification

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Gastric Cancer
Renal Cell Carcinoma
Lung Adenocarcinoma
Gastric Adenocarcinoma
Cholangiocarcinoma
Colorectal Cancer
Gastroesophageal Cancer
Glioblastoma
Lung Cancer
Head and Neck Cancer
Gallbladder Cancer
Solid Tumor
Sarcoma
Biliary Tract Cancer
Hepatocellular Cancer
Gastroesophageal Junction Adenocarcinoma
HER2 Positive Breast Cancer
Pancreatic Cancer
crizotinib
savolitinib
tepotinib
TPX-0022
capmatinib
U3-1402
REGN5093
gefitinib + savolitinib
TQ-B3101
APL-101
crizotinib + osimertinib
osimertinib + savolitinib
gefitinib + CT053PTSA
erlotinib + gefitinib + icotinib
SCC244
gefitinib + tepotinib
bevacizumab + crizotinib
RG3638
JNJ-38877605
afatinib
osimertinib
lorlatinib
Immunotherapy
SGX523
cetuximab
savolitinib + capmatinib
c-MET inhibitor
AMG 102
cediranib
GB263T
selpercatinib
erlotinib
cabozantinib tablet
osimertinib + HQP8361
HQP8361
gefitinib
CKD-702
panitumumab
trastuzumab